Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome
Treatment of Sprague-Dawley rats with AY9944, an inhibitor of 3β-hydroxysterol-Δ7-reductase (Dhcr7), leads to elevated levels of 7-dehydrocholesterol (7-DHC) and reduced levels of cholesterol in all biological tissues, mimicking the key biochemical hallmark of Smith-Lemli-Opitz syndrome (SLOS). Four...
Main Authors: | Libin Xu, Wei Liu, Lowell G. Sheflin, Steven J. Fliesler, Ned A. Porter |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-10-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520408454 |
Similar Items
-
Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients[S]
by: Wei Liu, et al.
Published: (2013-01-01) -
Probing lipid-protein adduction with alkynyl surrogates: application to Smith-Lemli-Opitz syndrome[S]
by: Katherine Windsor, et al.
Published: (2013-10-01) -
Smith-Lemli-Opitz Syndrome
by: J Gordon Millichap
Published: (1998-09-01) -
Effect of a new inhibitor of cholesterol biosynthesis (AY 9944) on serum and tissue sterols in the rat
by: L. Horlick
Published: (1966-01-01) -
Effect of long-term administration of AY-9944, an inhibitor of 7-dehydrocholesterol Δ7-reductase, on serum and tissue lipids in the rat
by: D. Dvornik, et al.
Published: (1968-09-01)